GlassScriptPhysician profile
Terrence A Cronin
NPI 1356343115
$553.32
in general payments reported to CMS, 2019-2025
14 companies · $18.57 in 2025
The $18.57 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $87.07 · 2022: $57.42 · 2023: $247 · 2024: $143 · 2025: $18.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $344 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $65.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $343.83 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $65.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $117.08 | 2023 | Opzelura |
| Regeneron Pharmaceuticals, INC. | $99.12 | 2024 | Dupixent |
| Almirall LLC | $44.06 | 2022-2023 | Klisyri |
| Amgen INC. | $43.91 | 2024 | Otezla |
| Regeneron Healthcare Solutions, INC. | $38.71 | 2021-2023 | Libtayo |
| Lilly USA, LLC | $36.12 | 2021 | |
| Kerecis Limited | $30.44 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| E.R. Squibb & Sons, L.L.C. | $28.00 | 2023 | Sotyktu |
| Organogenesis INC. | $24.49 | 2023 | Puraply |
| Biofrontera INC. | $21.29 | 2023 | Xepi, Bf-Rhodoled, Ameluz |
| Leo Pharma INC. | $20.69 | 2023 | Adbry |
| Galderma Laboratories, L.P. | $18.35 | 2022 | |
| Stemline Therapeutics INC. | $16.84 | 2021 | |
| Genzyme Corporation | $14.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terrence Cronin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.